Informazione:
Errore:
ID
20195
Descrizione
Open Label Study Of SU011248 In Combination With Trastuzumab For Patients With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00243503
collegamento
https://clinicaltrials.gov/show/NCT00243503
Keywords
versioni (1)
- 11/02/17 11/02/17 -
Caricato su
11 febbraio 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Eligibility Breast Neoplasms NCT00243503
Eligibility Breast Neoplasms NCT00243503
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT00243503
- StudyEvent: Eligibility
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Unresectable or metastatic breast cancer
Item
a diagnosis of breast cancer with evidence of 1) unresectable, locally recurrent, or 2) metastatic disease.
boolean
C1519810 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0278488 (UMLS CUI [2])
C0678222 (UMLS CUI [1,2])
C0278488 (UMLS CUI [2])
Her2 positive disease
Item
her2 positive disease (3+ by immunohistochemistry [ihc] or fish-positive)
boolean
C1960398 (UMLS CUI [1])
Trastuzumab
Item
candidate for treatment with trastuzumab. prior treatment with trastuzumab and or/
boolean
C0728747 (UMLS CUI [1])
Lapatinib or hormone therapy
Item
lapatinib in the neoadjuvant, adjuvant or metastatic disease setting is permitted. treatment with hormone therapy in the adjuvant and/or advanced disease setting is permitted.
boolean
C1506770 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0279025 (UMLS CUI [2])
Prior chemotherapy
Item
prior treatment with >1 regimen of cytotoxic therapy in the advanced disease setting. adjuvant chemotherapy is permitted
boolean
C1514457 (UMLS CUI [1])
Hypersensitivity to trastuzumab
Item
prior exposure to trastuzumab if the patient had developed severe hypersensitivity reactions.
boolean
C0020517 (UMLS CUI [1,1])
C0728747 (UMLS CUI [1,2])
C0728747 (UMLS CUI [1,2])
Study status
Item
prior treatment on a su11248 clinical trial.
boolean
C2348568 (UMLS CUI [1])
Brain metastases
Item
uncontrolled brain metastases.
boolean
C0220650 (UMLS CUI [1])